Top Stories for Week of March 9, 2020

      No Comments on Top Stories for Week of March 9, 2020

COVID-19 Addenda: Trump signs $8.3 billion emergency spending package; Italy coronavirus deaths near 200; $2 billion needed to develop new vaccine; U of Washington has closed classrooms. President Donald Trump… Read more »

Top Stories for Week of March 2, 2020

As the situation worsens, Gilead begins two, late-stage studies to test drug for coronavirus. The coronavirus, or COVID-19, has infected more than 80,000 people in about three dozen countries since… Read more »

Top Stories for Week of February 24, 2020

      No Comments on Top Stories for Week of February 24, 2020

TOP  STORIES Aided by machine learning (AI), scientists find novel antibiotic able to kill superbugs. A powerful antibiotic that kills some of the most dangerous drug-resistant bacteria in the world… Read more »

China records more than 2,000 new coronavirus cases in 24 hours; CDC director says CIVUD-19 probably with us beyond this year.

The News: China’s National Health Commission on Monday reported 2,048 new cases of coronavirus infections and 105 new deaths over the previous 24 hours. The number of new deaths dropped… Read more »

Medical Stock Spotlight – market’s stampede into stocks that could, even remotely, benefit from the coronavirus outbreak

Thinly traded nano cap Cleveland BioLabs Inc. (Nasdaq:CBLI) led advancing issues, skyrocketing 220% over the week to $4.23 as yet another company is caught up in the market’s stampede into… Read more »

Trump changes Medicaid

      No Comments on Trump changes Medicaid

The News: The Trump administration on Thursday (February 6, 2020) said it will experiment with allowing state Medicaid programs to limit health benefits and prescription drug coverage for some patients… Read more »

As deaths surge, WHO says too early to declare coronavirus peaking in China, elsewhere.

The News: An American citizen has died in Wuhan, China, from the coronavirus epidemic, with the death toll edging closer to the total from SARS (severe acute respiratory syndrome, circa… Read more »

2020’s health-sector IPO action is blasting off with the pricing of a China-based biggie and a bunch of new filings.

The US health-sector IPO action continues to scramble for public funding leadership. And it’s beginning with a Chinese company that raked in over $100 million. Let’s check out the action… Read more »

Drug regulators in China, US and Europe out of the gates in 2020 with a whole month’s worth of action.

Slowly at first, then accelerating recently in its domestic and global footprint in drug research and regulation, China and its National Medical Products Administration (NMPA) has been on a tear…. Read more »

Health-sector IPO action picks up where 2019 left off with new SEC filings signaling high hopes for cash still parked on the sidelines.

Despite clashes over trade sanctions pending resolution with China and threats of war with Iran escalating to nerve-wracking heights, confidence in the US market for health-sector initial public offerings apparently… Read more »